| |
|
|
|
|
|
|
|||
|
S Ravel, M Colombatti and P Casellas
Department of Immunology, Sanofi Recherche, Montpellier, France.
We have investigated the entry and subsequent intracellular fate of T101
monoclonal antibody (MoAb) and T101-ricin A-chain (RTA) immunotoxin (IT)
directed against the CD5 antigen (Ag) expressed on human leukemic CEM
cells. We provide direct evidence for the internalization of T101 MoAb and
the corresponding IT. Both the MoAb and IT were internalized at a
relatively low rate. This slow internalization process could be related to
the partial recycling of the MoAb/Ag or IT/Ag complexes. Analysis of the
internalized molecules showed that their molecular weight was only
partially altered after internalization and that no free A-chain could be
found inside the cells, indicating that lysosomal degradation and cleavage
of disulfide- linked conjugates is a quantitatively minor phenomenon
compared with the localization of internalized anti-CD5 ITs in an
endosomo-Golgi compartment, followed by their recycling to the cell
surface. We believe that this is the major factor explaining the low
efficacy of anti-CD5 IT when assayed in the absence of potentiating
substances. Finally, we showed that the presence of ammonium chloride and
monensin, which both dramatically enhance the kinetics of IT activity, did
not affect the rate of internalization or the intracellular localization of
the conjugate, suggesting that these activators could act at the
postendocytotic level on a limited number of IT molecules.
This article has been cited by other articles:
| |||||||||||
| Copyright © 1992 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||